Health Aug 20 Moderna shares surge after it says experimental mRNA cancer treatment passed key test By Associated Press
Politics May 05 White House says Trump's deals with pharmaceutical companies offer billions in savings WASHINGTON (AP) — White House economists estimate that President Donald Trump's deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they charge in other countries could save $529 billion over the next 10 years. By Josh Boak, Associated Press
Politics Apr 23 WATCH: Trump unveils deal with Regeneron to lower its drug prices for Medicaid President Donald Trump on Thursday announced a deal with drugmaker Regeneron to lower the cost of its pharmaceutical products as part of the White House's signature drug pricing initiative. By Ali Swenson, Associated Press
Health Dec 19 WATCH: Trump announces 9 pharmaceutical companies will lower drug prices Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will now rein in Medicaid drug prices to match what they charged in other developed countries. By Sally Ho, Associated Press
World Aug 01 EU chief's texts to a pharma boss during pandemic were likely erased, New York Times reports Text messages exchanged between European Commission President Ursula von der Leyen and a pharmaceutical boss during the COVID-19 pandemic were seen by her top adviser and have likely been destroyed, the New York Times reported Friday. By Lorne Cook, Associated Press
Jul 31 Watch 9:58 As opioid settlement money starts to flow in, states debate how best to use it By Cat Wise, Mike Fritz More than $50 billion in settlement funds from pharmaceutical companies that made and sold opioid painkillers will be paid out over the next 18 years to state and local governments across the country. But the debate around how this money… Continue watching
Jul 28 Watch 8:56 How the prescription drug supply chain is killing local pharmacies By Fred de Sam Lazaro The supply chain that brings pharmaceutical drugs from the factory to the pharmacy is long, complex and unclear. Congress and several state legislatures have proposed or enacted laws to bring more transparency and curb soaring drug prices. As special correspondent… Continue watching
Jul 19 DEA official resigns amid reports of previous Big Pharma consulting work By Joshua Goodman, Jim Mustian, Associated Press Louis Milione’s four years of consulting for Big Pharma preceded his 2021 return to the DEA to serve as Administrator Anne Milgram’s top deputy, renewing concerns in the agency and beyond about the revolving door between government and industry and… Continue reading
Aug 10 Groups make own drugs to fight high drug prices, shortages By Linda A. Johnson, Associated Press Impatient with years of inaction in Washington on prescription drug prices, U.S. hospital groups, startups and nonprofits have started making their own medicines. Continue reading
Aug 25 Watch 5:54 Tracking the flow of opioids across America The manufacturers and distributors of opioid prescription painkillers have supplied billions of pills throughout the U.S. An investigative series by The Washington Post looks at the opioid epidemic through the DEA's newly public database that tracks every pain pill sold… Continue watching